Review
Transfusion therapy in congenital coagulopathies
Affiliations
- PMID: 7860443
Item in Clipboard
Review
Transfusion therapy in congenital coagulopathies
Hematol Oncol Clin North Am.
1994 Dec.
Abstract
Transfusion therapy for the congenital coagulopathies has changed considerably in recent years. Improved donor screening, purification, and virucidal methodologies have resulted in much safer plasma-derived clotting factor concentrates. Additionally, synthetic products such as rF VIII and DDAVP are licensed and available. For persons with hemophilia B, nonthrombogenic coagulation F IX concentrates are available. Treatment recommendations for each of the congenital coagulopathies are discussed.
Similar articles
-
Use of blood products and factor concentrates for coagulation therapy.Clin Lab Sci. 2003 Spring;16(2):115-9. Clin Lab Sci. 2003. PMID: 12757192 Review.
-
Drug therapy reviews: clinical use of hemostatic agents.Am J Hosp Pharm. 1978 Apr;35(4):414-22. Am J Hosp Pharm. 1978. PMID: 306196
-
[Modern trends in the therapy of congenital and acquired coagulopathies].Clin Ter. 1968 Jun 15;45(5):469-93. Clin Ter. 1968. PMID: 4901167 Review. Italian. No abstract available.
-
[Substitution therapy of coagulopathies].Infusionstherapie (1973). 1974 Aug;1(6):447-53. Infusionstherapie (1973). 1974. PMID: 4466806 German. No abstract available.
-
Hereditary disorders of blood coagulation.Major Probl Intern Med. 1976;10:51-64. Major Probl Intern Med. 1976. PMID: 785116 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical